These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29395629)

  • 1. Local Control After Stereotactic Body Radiation Therapy for Liver Tumors.
    Ohri N; Tomé WA; Méndez Romero A; Miften M; Ten Haken RK; Dawson LA; Grimm J; Yorke E; Jackson A
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):188-195. PubMed ID: 29395629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractionated stereotactic radiation therapy for brain metastases: a systematic review with tumour control probability modelling.
    Baliga S; Garg MK; Fox J; Kalnicki S; Lasala PA; Welch MR; Tomé WA; Ohri N
    Br J Radiol; 2017 Feb; 90(1070):20160666. PubMed ID: 27936894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local Control Outcomes Using Stereotactic Body Radiation Therapy for Liver Metastases From Colorectal Cancer.
    Joo JH; Park JH; Kim JC; Yu CS; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Yoon SM; Park J; Kim JH
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):876-883. PubMed ID: 29063852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.
    Stera S; Balermpas P; Chan MKH; Huttenlocher S; Wurster S; Keller C; Imhoff D; Rades D; Dunst J; Rödel C; Hildebrandt G; Blanck O
    Strahlenther Onkol; 2018 Feb; 194(2):143-155. PubMed ID: 28875297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiation therapy for patients with heavily pretreated liver metastases and liver tumors.
    Lanciano R; Lamond J; Yang J; Feng J; Arrigo S; Good M; Brady L
    Front Oncol; 2012; 2():23. PubMed ID: 22645716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
    Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
    Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
    Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
    J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.
    Andratschke N; Parys A; Stadtfeld S; Wurster S; Huttenlocher S; Imhoff D; Yildirim M; Rades D; Rödel CM; Dunst J; Hildebrandt G; Blanck O
    Radiat Oncol; 2016 May; 11():74. PubMed ID: 27236333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.
    Méndez Romero A; Schillemans W; van Os R; Koppe F; Haasbeek CJ; Hendriksen EM; Muller K; Ceha HM; Braam PM; Reerink O; Intven MPM; Joye I; Jansen EPM; Westerveld H; Koedijk MS; Heijmen BJM; Buijsen J
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1377-1386. PubMed ID: 33451857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation Therapy.
    Ahmed KA; Caudell JJ; El-Haddad G; Berglund AE; Welsh EA; Yue B; Hoffe SE; Naghavi AO; Abuodeh YA; Frakes JM; Eschrich SA; Torres-Roca JF
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1399-1404. PubMed ID: 27319288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.
    Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R
    Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis.
    Chang DT; Swaminath A; Kozak M; Weintraub J; Koong AC; Kim J; Dinniwell R; Brierley J; Kavanagh BD; Dawson LA; Schefter TE
    Cancer; 2011 Sep; 117(17):4060-9. PubMed ID: 21432842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
    Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer.
    Mahadevan A; Moningi S; Grimm J; Li XA; Forster KM; Palta M; Prior P; Goodman KA; Narang A; Heron DE; Lo SS; Urbanic J; Herman JM
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):206-216. PubMed ID: 33358561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy.
    McCammon R; Schefter TE; Gaspar LE; Zaemisch R; Gravdahl D; Kavanagh B
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):112-8. PubMed ID: 18786780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiation therapy for stage I non-small cell lung cancer: The importance of treatment planning algorithm and evaluation of a tumor control probability model.
    Ohri N; Tomé W; Kalnicki S; Garg M
    Pract Radiat Oncol; 2018; 8(2):e33-e39. PubMed ID: 29233523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic Body Radiation Therapy in Primary and Metastatic Liver Disease.
    Caivano D; Valeriani M; Russo I; Bonome P; DE Matteis S; Minniti G; Osti MF
    Anticancer Res; 2017 Dec; 37(12):7005-7010. PubMed ID: 29187487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation.
    Franzese C; Comito T; Clerici E; Di Brina L; Tomatis S; Navarria P; Reggiori G; Viganò L; Poretti D; Pedicini V; Torzilli G; Solbiati L; Scorsetti M
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1777-1783. PubMed ID: 29934790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiation therapy for liver metastasis from colorectal cancer: size matters.
    Flamarique S; Campo M; Asín G; Pellejero S; Viúdez A; Arias F
    Clin Transl Oncol; 2020 Dec; 22(12):2350-2356. PubMed ID: 32488803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy.
    Davis JN; Medbery C; Sharma S; Danish A; Mahadevan A
    Radiat Oncol; 2013 Nov; 8():275. PubMed ID: 24274599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.